SlideShare a Scribd company logo
THE physicochemical properties AND ACTIVITY.ppt
DEFINITION:
 The ability of a chemical compound to elicit a
pharmacological/ therapeutic effect is related to
the influence of various physical and chemical
(physicochemical) properties of the chemical
substance on the bio molecule that it interacts
with.
1)Physical Properties
Physical property of drug is responsible for its action
2)Chemical Properties
The drug react extracellularly according to simple
chemical reactions like neutralization, chelation, oxidation
etc.
Various Physico-Chemical Properties
are,
 Solubility
 Partition Coefficient
 Ionization
 Hydrogen Bonding
 Chelation
 Surface activity
 Isosterism
ROUTES OF ADMINISTRATION
 The choice of appropriate route in a given situation depends
upon both drug as well as patient related factors.
 Drugs administered locally or systematically.
 The drugs administered through systemic routes is intended to
be absorbed into blood & distributed all over.
Different Routes Of Drug Administrations
Oral/ Oral/ Rectal Epithelial Inhalation
Parentral
Swallowed Sublingual
Topical: local effect, substance is applied directly where its action is desired.
 Epicutaneous (application onto the skin), e.g. allergy testing, typical local
anesthesia
 Inhalational, e.g. asthma medications
 Enema, e.g. contrast media for imaging of the bowel
 Eye drops (onto the conjunctiva), e.g. antibiotics for conjunctivitis
 Ear drops - such as antibiotics and corticosteroids for otitis externa
ABSORPTION:
 The process by which the drug is released in the body
from its dosage form is known as absorption.
 Drug absorption is the movement of a drug into the
bloodstream.
 The factors which effect the rate of absorption are
◦ Concentration of the drug
◦ Route of administration
◦ Solubility of the drug
◦ Dissolution rate for solid dosage form
◦ Blood circulation to the site of application and the area of the
absorbing surface in local applications.
◦ Physico-chemical parameters of the drug.
 To reach he site of action the drug has to cross one or more
membrane barriers .
 The main process by which a drug molecule cross the neutral
barrier is,
◦ Simple diffusion
◦ Facilitated diffusion
◦ Pore transport
◦ Diffusion of the ion across the membrane
◦ Active transport
◦ phagocytosis
7
DISTRIBUTION:
 Once the drug has been absorbed into the blood ,it
distributed around the body. It get distributed throughout
the blood supply , with in a minute. As the blood
recirculates, the drug moves from the bloodstream into
the body's tissues.
 Drug is evenly distributed through out the blood supply,
this does not mean the drug is evenly distributed around
the body . Since he blood supply is rich in some areas of
the body than the other.
8
 Drugs penetrate different tissues at different speeds,
depending on the drug's ability to cross membranes. For
example, the anesthetic thiopental, a highly fat-soluble drug,
rapidly enters the brain, but the antibiotic penicillin, a water-
soluble drug, does not. In general, fat-soluble drugs can cross
cell membranes more quickly than water-soluble drugs can.
 Distribution of a given drug may also vary from person to
person. For instance, obese people may store large amounts
of fat-soluble drugs, whereas very thin people may store
relatively little. Older people, even when thin, may store large
amounts of fat-soluble drugs because the proportion of body
fat increases with aging.
9
METABOLISM:
 Drug metabolism is the chemical alteration of a drug by
the body.
 metabolism is what the body does to the drug,
Some drugs are chemically altered by the body
(metabolized). The substances that result from
metabolism (metabolites) may be inactive, or they may
be similar to or different from the original drug in
therapeutic activity or toxicity. Some drugs, called
prodrugs, are administered in an inactive form, which is
metabolized into an active form.
10
 The resulting metabolites produce the desired
therapeutic effects. Metabolites may be metabolized
further instead of being excreted from the body. The
subsequent metabolites are then excreted . The
termination of the drug effect is caused by bio
transformation and excretion .all the substance in the
circulatory system , including drugs ,metabolites ,and
nutrients will pass through the liver.
 A significant portion of the drug metabolised by hepatic
enzyme to inactive chemical.
11
Storage sites
 Plasma proteins, certain tissues, neutral fat, bone and
transcelluar fluids(gastro intestinal tract)are found to act
as a drug reservoirs or storage sites for drugs.
 Plasma proteins: approximately 6.5% of the blood
constitute the proteins, of which 50% I albumin.
 The drug can also be stored in the tissue depots. Neutral
fat constitutes some 20%o 50% of body weight and
constitutes a depot of considerable importance.
12
 The more lipophilic the drug, the more likely it will concentrate in
these pharmacologically inert depots. The ultra short acting,
lipophilic barbiturate thiopental’s concentration rapidly decreases
below its effective concentration following administration. It
disappears into tissue protein, redistributes into body fat, and then
slowly diffuses back out of the tissue depots but in concentrations
too low for a pharmacological response.
 In general, structural changes in the barbiturate series that favours
partitioning into the lipid tissue stores decrease duration of action
but increase central nervous system depression. Conversely, the
barbiturates with the slowest onset of action and longest duration of
action contain the more polar side chains.
13
PROTEIN BINDING:
 The reversible binding of protein with non-specific and
non- functional site on the body protein with out
showing any biological effect is called as protein
binding.
 Protein + drug Protein-drug complex
⇌
 Depending on the whether the drug is a weak or
strong acid ,base or is neutral. It can bind to single
blood proteins to multiple proteins. The most
significant protein involved in the binding of drug is
albumin, which comprises more than half of blood
volume.
14
 protein binding values are normally given as the percentage
of total plasma concentration of drug that is bound to all
plasma protein.
15
Free drug(Df) + Free protein(Pf) Drug /protein complex (Dp)
Total plasma concentration (Dt) = (Df) (Dp
+
 NEUTRAL FAT:
 Since fat constituents around 10%(starvation) to 50% of the total
body weight.it serves as a main storage site for drugs having a high
partition coefficient(lipid/water system) or a high lipid
solubility(thiobarbiturates).
16
Drug Receptor Interactions
RECEPTOR
 A macromolecular component of the organism that binds
the drug and initiates its effect.
 Traditional model was a rigid “Lock and Key”
– Lock  Receptor surface
– Key  Drug or Ligand
TYPES OF RECEPTORS
Four Primary Receptor Families
(i)Ligand-gated ion channels
(ii) G-protein (Guanine nucleotide-regulatory protein) coupled
receptors.
iii) Tyrosine Kinase-linked Receptors
(iv) Intracellular receptors regulating gene transcription
THE physicochemical properties AND ACTIVITY.ppt
Covalent interactions
Ionic interactions
Drug
Receptor Interactions Hydrogen bonding
interactions
Vander Waals interactions
Hydrophobic interactions
Solubility:
• The solubility of a substance at a given temperature is defined
as the concentration of the dissolved solute, which is in
equillibrium with the solid solute.
• Sufficient solubility and membrane permeability is an
important factor for oral absorption.
• The measurement of aqueous solubility depends upon the
following facts.,
1) Buffer & Ionic strength
2) Polymorphism & Purity of the sample
3) pH
4) Super saturation
5) Thermodynamic Vs Kinetic solubility
 In ascending homologous series, the Physico chemical
properties like boiling point, viscosity, surface activity and
partition coefficient increases then the aqueous solubility
decreases.
 The solubility characteristics of a drug can be increased or
decreased by derivatisation.
 Eg: Methyl predinisolone acetate(water insoluble) is changed
to Methyl predinisolone Sodium succinate(water soluble).
 Eg: Convertion of chloramphenicol(slightly soluble) to
chloramphenicol Palmitate (insoluble)
 Methods to improve solubility of drugs
1) Structural modification
2) Use of co solvents
3) Employing surfactants
4) Complexation
Partition Co-efficient
 Partition co-efficient is one of the Physico chemical parameter
which influencing the drug transport & drug distribution., the
way in which the drug reaches the site of action from the site
of application.
 Partition co-efficient is defined as equilibrium constant of drug
concentration for a molecule in two phases.
 P[Unionized molecule] = [drug]lipid
[drug]water
P[Ionized molecule] = [drug]lipid
[1-a ][drug]water
a=degree of ionization in aqueous solution.
 Factors affecting Partition Co-efficient
 pH
 Cosolvents
 Surfactant
 Complexation
 Partition Co-efficient are difficult to measure in living
system.
 They are usually determined in vitro 1-octanol as a lipid
phase and phosphate buffer of pH 7.4 as the aqueous
phase.
• The Partition co-efficient, P is dimensionless and its
logarithm, log P is widely used as the measure of
lipophilicity.
• The log P is measured by the following methods.
1) Shake flask method
2) Chromatographic method
3) Spectroscopy method
• Phenobarbitone has a high lipid/water partition
coefficient of 5.9. Thiopentone sodium has a
chloroform/water partition coefficient of about
100, so it is highly soluble in lipid.
Surface Activity:
 surfactant is defined as a material that can reduce the surface
tention of water at low concentration.
 Surface active agents affect the drug absorption
which depends on:
1.The chemical nature of surfactant
2.Its concentration
3.Its affect on biological membrane and the miscelle
formation.
 At lower concentration the surfactant enhances
the absorption rate, the same in higher
concentration reduce the absorption rate.
Applications:
1.The antihelmentic activity of hexylresorcinol
2.Bactericidal activity of cationic quaternary
ammonium compounds.
3.Bactericidal activity of aliphatic alcohols.
4.Disinfectant action of phenol and cresol.
Hydrogen Bond
 The hydrogen bond is a special dipole-dipole interaction between non
bonding electron pairs of hetero atoms like N, S, O and electron deficient
hydrogen atom in polar bonds such as OH, NH, F etc.
These are weak bonds and denoted as dotted lines.
O-H…….O, HN-H…….O,
• The compounds that are capable, of forming hydrogen
bonding is only soluble in water.
 Hydrogen bonding is classified in 2 types.
1) Intermolecular hydrogen bonding
R-O-H
H
O R
H-O-R
H
H O H
H O H
O H
H
2) Intramolecular Hydrogen bonding
salicylic acid o-
nitrophenol
O H
C
O
OH
O H
N
O
O
Hydrogen Bonding and biological action
Eg. 1) Antipyrin i.e. 1- phenyl 2,3- dimethyl 5-
pyrazolone has analgesic activity.
N
N
CH3
H3C
O
C6H5
HN
H3C
O
C6H5
HN
H
N
H3C
O
1-phenyl-3-methyl-5-pyrazolone is inactive.
1-phenyl-3-methyl-5-pyrazolone is inactive.
C
O
H
O
OH
Salicylic acid(O-Hydroxy Benzoic acid has antebacterial activity
Salicylic acid(O-Hydroxy Benzoic acid has antebacterial activity
OH C
OH
O
HO C
O
OH
para and meta Hydroxy Benzoic acids are inactive.
para and meta Hydroxy Benzoic acids are inactive.
CHELATION
 DEFINITON: The compounds that are
obtained by donating electrons to a metal
Ion with the formation of a ring structure are
called chelates.
 LIGANDS: The compounds capable of
forming a ring structure with a metal are
termed as ligands.
Importance of chelates in medicine:
CH2SH
CHSH
CH2OH
+ As++
CH2S
CHS
CH2OH
As
a)Antidote for metal poisoning
1.Dimercaprol is a chelating agent.
CH3 C
CH3
SH
H
C
NH2
COOH
CU++
CH3 C
CH3
S
H
C
NH2
COOH
CU
CH3 C
CH3
S
H
C
NH2
COOH
UC
NH2 S
HOOC
CH3
CH3
2.Penicillamine
2.Penicillamine
1:1 chelate
1:2 chelate
 b)8-Hydroxyquinoline and its analogs acts as antibacterial and
anti fungal agent by complexing with iron or copper.
 C) Undesirable side effects caused by drugs, which chelates
with metals .
 A side effect of Hydralazine a antihypertensive agent is
formation of anemia and this is due to chelation of the drug
with iron.
Redox Potential:
 The oxidation-reduction potential may be defined as a
quantitative expression of the tendency that a compound has to
give or receive electrons.
 The redox potential of a system may be calculated from the
following equation.
 E=E0+0.0592/n log[conc. of reductant /conc.of oxidant]
 Examples of interfering with natural redox system in
biological conditions:
 1) Riboflavin analogues
 The biological activity of riboflavin is due to E =-0.185
volt.
Examples,
1) Riboflavin analogues
The biological activity of riboflavin is due to E =-
0.185 volt.
N
NH
O
N
OH
OH
OH
OH
N O
riboflavin
Riboflavin E0 = -0.185 V
Riboflavin analogue E0 = -0.095V
N
NH
O
N
OH
OH
OH
OH
N O
Dichloro riboflavin
Cl
Cl
2).The optimum bacteriostatic activity in quinones is associated
with the redox potential at +0.03 volt, when tested against
Staphylococcus aureus.
Ionisation and Pka
 Most of the drugs are either weak acids or base and can
exist in either ionised or unionised state.
 The ionisation of the drug depends on its pKa & pH.
 The rate of drug absorption is directly proportional to the
concentration of the drug at absorbable form but not the
concentration of the drug at the absorption site.
 Eg: Aspirin in stomach will get readily absorbed because it is in
the un-ionosed form(99%).
 Eg; Barbituric acid is inactive because it is strong acid.
5,5 disubstituted Barbituric acid has CNS depressant
action because it is weak acid.
Acids are two types-Unionized acid - HA
Ionized acid - BH +
According to Henderson-Hasselbalch equation
PH
= pka
+log[Un ionised form][ionised form
% ionisation = 100( 1+10 (pH-pka)
)
HA H2O H3O+
A-
BH+ H2O H3O+
B
Unionized
Acid
Conjugate
acid
Conugate
base
ionised Conugate
acid
Conugate
base
 By using drug pKa, the formulation can be adusted to pH to
ensure maximum solubility in water or maximum solubility in
non-polar solvent.
 The PH of a substance can be adjusted to maintain
water solubility and complete ionisation.
 Eg:Phenytoin injection must be adjusted to Ph
12 with Sodium
Hydroxide to obtain 99.98% of the drug in ionised form.
 Tropicamide eye drops,an anti cholinergic drug has a pka of
5.2 and the drug has to be buffered to Ph
4 to obtain more than
90% ionisation.
OH
O
H
OH
O
H
trans-diethylstibesterol
Estrogenic activity
cis-diethylstibesterol
Only 7% activity
of the trans isomer
The drug most possess a high degree of structural specificity or stereo
selectivity.
Many drugs show stereo selectivity because mostly reeptor binds are optically
active biological macromolecules such as protein, polynuclootide or glycolipds.
For e.g. Diethyl stilbosterol
Conformational Isomers
 Different arrangement of atoms that can be converted into
one another by rotation about single bonds are called
conformations.
 Rotation about bonds allows inter conversion of conformers.
 A classical example is of acetylcholine which can exist in different
conformations.
Staggered
2-Acetoxycyclo propyl trimethyl ammonium iodide
H H
N+
H
H
OCOCH3
H
H
N+
H
H
OCOCH3
Eclipsed
H3COCO H
N
H
H
H
GAUCHE
H
OCOCH3
N
H
H
H
Fully Eclipsed
N+
O
O
I-
 Optical Isomers
 Stereochemistry, enantiomers, symmetry and chirality
are impotant concept in therapeutic and toxic effect
of drug.
 A chiral compound containing one asymmetric centre
has two enantiomers. Although each enantiomer has
identical chemical & physical properties, they may have
different physiological activity like interaction with
receptor, metabolism & protein binding.
 A optical isomers in biological action is due to one
isomer being able to achieve a three point attachment
with its receptor molecule while its enantiomer would
only be able to achieve a two point attachment with
the same molecule.
(-)-Adrenaline
(+)-Adrenaline
E.g. Ephedrine & Psuedoephedrine
MP = 37-39
1 gram/20 mL
MP = 118-120
1 gram/200 mL
Ephedrine
(Erythro)
CH3
OH
H
NHCH3
H
Pseudoephedrine
(Threo)
CH3
H
O
H
NHCH3
H
 The category of drugs where the two isomers have
qualitatively similar pharmacological activity but have
different quantitative potencies.
O
O
OH
O
(s)-(-)warfarin
O
O
OH
O
(R)-(+)warfarin
Geometric Isomerism
Geometric isomerism is represented by cis/trans
isomerism resulting from restricted rotation due to
carbon carbon double bond or in rigid ring system.
OH
O
H
OH
O
H
trans-diethylstibesterol
Estrogenic activity
cis-diethylstibesterol
Only 7% activity
of the trans isomer
 Longmuir introduced the term isosterism in 1919, which
postulated that two molecules or molecular fragments
containing an identical number and arrangament of electron
should have similar properties and termed as isosteres.
 Isosteres should be isoelectric i.e. they should possess same
total charge.
 Bioisosterism is defined as compounds or groups that possess
near or equal molecular shapes and volumes, approximately
the same distribution of electron and which exhibit similar
physical properties.
 They are classified into two types.,
i)Classical biososteres
ii)Non classical bioisosters.
 Classical Bioisosteres
 They have similarities of shape and electronic configuration of
atoms, groups and molecules which they replace.
 The classical bioisosteres may be,
Univalent atoms and groups
i)cl, Br, I ii) CH3NH2, -OH, -SH
Bivalent atoms and groups
i) R-OR,RNH-R, RSR,RSeR
ii) –CONHR, -COOR, -COSR
 Trivalent atoms and groups
i)-CH=, -N= ii) –p=, -AS=
 Tetravalent atoms and groups
=c=, =N=, =P=
 Application of Classical Bioisosteres in in drug design
i) Replacement of –NH 2 group by –CH3 group.
Carbutamide R= NH2
Tolbutamide R= CH3
ii)Replacement of –OH & -SH
Guanine= -OH
6-Thioguanine = -SH
R SO2 NH CONH(CH2)3CH3
NH
N
N
H2N
HN
X
 Non classical Bioisosteres
 They do not obey the stearic and electronic
definition of classical isosteres.
 These isosteres retain activity by the retention of
their properties such as pKa, electrostatic
potentials, which can alter selective enzyme
processes.
 Examples
 Halogens cl, F, Br,CN
 Ether -S-, -O-
 Carbonyl group
 Hydroxyl group –OH, -NHSO2R, CH2OH
 Catechol
HO
HO
Catechol
O
S
O O
N
H
N
 A classical e.g. of ring Vs. noncycclic structure is
Diethylstilbosterol & 17-ß oestradiol.
17-ß oestradiol.
HO
OH
H
H
H
OH
HO
trans-diethylstibesterol
REFERENCES:
1.Thomas L . LEMKE , David A . WILLIAMS , Victoria
F.ROCHE,S . William ZITO, Foye’s Principles of
Medicinal Chemistry ,Wolters kluwer Pvt .Ltd, New
Delhi , 6th
Edition ,Pg . no. 210 – 298.
2.William A.Remers,Jaimes N .Delgado, Wilson&
Grissvold’s Text book of organic, Medicinal and
pharmaceutical Chemistry ,10th
Edition ,Pg .no.3-10
59
3. DonaldJ. Abraham ,BURGER’S Medicinal chemistry Drug
Discovery , Wiley inter science publication ,
6th
Edition ,Volume -2, Pg. no. 649 – 653.
4. Rama rao Nadendla ,Principles of organic Medicinal Chemistry ,
New age International Pvt . Limited Publishers , Pg . no. 14 - 28.
5. www.wikipedia.com
60
THANK YOU

More Related Content

PPT
physicochemical properties of Drug (1).ppt
PPTX
General pharmacology and pharmocokinetics
PPTX
PHARMACOKINETICS.pptx
PPTX
ppt on pharmacokinetics pharmacolocy
PPTX
Manjot kaur 2.pptx pharmacokinetics 2 ppt
PPT
Applied pharmacology
PPTX
introducton toPHARMACOLOGY lecturevnotes
PPTX
General pharmacology
physicochemical properties of Drug (1).ppt
General pharmacology and pharmocokinetics
PHARMACOKINETICS.pptx
ppt on pharmacokinetics pharmacolocy
Manjot kaur 2.pptx pharmacokinetics 2 ppt
Applied pharmacology
introducton toPHARMACOLOGY lecturevnotes
General pharmacology

Similar to THE physicochemical properties AND ACTIVITY.ppt (20)

PPTX
pharmacokinetics- a detailed and easy way to learn
PDF
L P- 2 Pharmacokinetics final_١٢٥٧٠٠.pdf
PPTX
Drug distribution & drug elimination pharmacology
PPT
Pharmacokinetics
PPTX
PHARMACOKINETICS (1).pptx for nursing students
PPTX
Pharmacokinetics
PPTX
PHARMACOKINETIC
PPTX
Pharmacokinetics pharmacology medicine .pptx
PPT
Pharmacokinetics
PPTX
Basic principles of pharmacology
PDF
basicprinciplesofpharmacology-180511150709.pdf
PDF
Pharmacokinetic and pharmacodynamic
PPTX
2-Pharmacokinetics (2).pptx234567890qwertyuio
PPTX
Pharmacokinitic
PDF
Pharmacokinetics study
PPTX
Basic OF medicinal Chemistry and drug II.pptx
PPTX
Pharmacokinetics - ADME
PPT
Absorption and distribution of drugs
PPTX
Basic principles
PPTX
Basic principles
pharmacokinetics- a detailed and easy way to learn
L P- 2 Pharmacokinetics final_١٢٥٧٠٠.pdf
Drug distribution & drug elimination pharmacology
Pharmacokinetics
PHARMACOKINETICS (1).pptx for nursing students
Pharmacokinetics
PHARMACOKINETIC
Pharmacokinetics pharmacology medicine .pptx
Pharmacokinetics
Basic principles of pharmacology
basicprinciplesofpharmacology-180511150709.pdf
Pharmacokinetic and pharmacodynamic
2-Pharmacokinetics (2).pptx234567890qwertyuio
Pharmacokinitic
Pharmacokinetics study
Basic OF medicinal Chemistry and drug II.pptx
Pharmacokinetics - ADME
Absorption and distribution of drugs
Basic principles
Basic principles
Ad

More from breenaawan (20)

PPT
physicochemical_properties_of_drug_molecules.ppt
PPTX
the significance of microbial growth.pptx
PPTX
the Hypersensitivity types with detail .pptx
PPTX
The sterilization and difference between narrown/broad spectrum antibiotics.pptx
PPTX
The antibodies with details in microbiology.pptx
PPTX
introduction to microbiology and basic terminology.pptx
PPTX
Role Of Skin And Mucous Membrane In Non Specific Resistance.pptx
PPTX
INTRODUCTION TO MICROBIOLOGY AND MICROORGANISMS (1).pptx
PPTX
Pharmacology of Major anticancerdrugs.pptx
PPTX
microbiology the health`chp 3 topic 1.pptx
PPTX
Aseptic and infectionmicrobiology the full unit 4.pptx
PPT
dnareplicationrepairundergrads-140407025100-phpapp02.ppt
PPTX
pharmacologyofdiabetesmellitus-191005121724 (1).pptx
PPT
The pharmacology of Gastrointestinal tract.ppt
PPTX
oxidativephos-140111054455-phpapp01.pptx
PPTX
unit 3 Defence Mechanism of the Body.pptx
PPT
unit 2 The control of microbial growth .ppt
PPT
Microbial growth control170713022721.ppt
PPTX
Asthma pharmacology drugs in detail2.pptx
PPTX
Asthma pharmacology detail drugs 2.pptx
physicochemical_properties_of_drug_molecules.ppt
the significance of microbial growth.pptx
the Hypersensitivity types with detail .pptx
The sterilization and difference between narrown/broad spectrum antibiotics.pptx
The antibodies with details in microbiology.pptx
introduction to microbiology and basic terminology.pptx
Role Of Skin And Mucous Membrane In Non Specific Resistance.pptx
INTRODUCTION TO MICROBIOLOGY AND MICROORGANISMS (1).pptx
Pharmacology of Major anticancerdrugs.pptx
microbiology the health`chp 3 topic 1.pptx
Aseptic and infectionmicrobiology the full unit 4.pptx
dnareplicationrepairundergrads-140407025100-phpapp02.ppt
pharmacologyofdiabetesmellitus-191005121724 (1).pptx
The pharmacology of Gastrointestinal tract.ppt
oxidativephos-140111054455-phpapp01.pptx
unit 3 Defence Mechanism of the Body.pptx
unit 2 The control of microbial growth .ppt
Microbial growth control170713022721.ppt
Asthma pharmacology drugs in detail2.pptx
Asthma pharmacology detail drugs 2.pptx
Ad

Recently uploaded (20)

PPTX
surgery guide for USMLE step 2-part 1.pptx
PPTX
Respiratory drugs, drugs acting on the respi system
PPTX
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
PDF
CT Anatomy for Radiotherapy.pdf eryuioooop
PDF
Medical Evidence in the Criminal Justice Delivery System in.pdf
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PPTX
post stroke aphasia rehabilitation physician
PPTX
Uterus anatomy embryology, and clinical aspects
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
DOC
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
PPTX
SKIN Anatomy and physiology and associated diseases
PPT
ASRH Presentation for students and teachers 2770633.ppt
PPTX
Imaging of parasitic D. Case Discussions.pptx
PPT
Breast Cancer management for medicsl student.ppt
PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PPT
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
PDF
Human Health And Disease hggyutgghg .pdf
surgery guide for USMLE step 2-part 1.pptx
Respiratory drugs, drugs acting on the respi system
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
CT Anatomy for Radiotherapy.pdf eryuioooop
Medical Evidence in the Criminal Justice Delivery System in.pdf
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
post stroke aphasia rehabilitation physician
Uterus anatomy embryology, and clinical aspects
MENTAL HEALTH - NOTES.ppt for nursing students
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
SKIN Anatomy and physiology and associated diseases
ASRH Presentation for students and teachers 2770633.ppt
Imaging of parasitic D. Case Discussions.pptx
Breast Cancer management for medicsl student.ppt
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
Human Health And Disease hggyutgghg .pdf

THE physicochemical properties AND ACTIVITY.ppt

  • 2. DEFINITION:  The ability of a chemical compound to elicit a pharmacological/ therapeutic effect is related to the influence of various physical and chemical (physicochemical) properties of the chemical substance on the bio molecule that it interacts with. 1)Physical Properties Physical property of drug is responsible for its action 2)Chemical Properties The drug react extracellularly according to simple chemical reactions like neutralization, chelation, oxidation etc.
  • 3. Various Physico-Chemical Properties are,  Solubility  Partition Coefficient  Ionization  Hydrogen Bonding  Chelation  Surface activity  Isosterism
  • 4. ROUTES OF ADMINISTRATION  The choice of appropriate route in a given situation depends upon both drug as well as patient related factors.  Drugs administered locally or systematically.  The drugs administered through systemic routes is intended to be absorbed into blood & distributed all over.
  • 5. Different Routes Of Drug Administrations Oral/ Oral/ Rectal Epithelial Inhalation Parentral Swallowed Sublingual Topical: local effect, substance is applied directly where its action is desired.  Epicutaneous (application onto the skin), e.g. allergy testing, typical local anesthesia  Inhalational, e.g. asthma medications  Enema, e.g. contrast media for imaging of the bowel  Eye drops (onto the conjunctiva), e.g. antibiotics for conjunctivitis  Ear drops - such as antibiotics and corticosteroids for otitis externa
  • 6. ABSORPTION:  The process by which the drug is released in the body from its dosage form is known as absorption.  Drug absorption is the movement of a drug into the bloodstream.  The factors which effect the rate of absorption are ◦ Concentration of the drug ◦ Route of administration ◦ Solubility of the drug ◦ Dissolution rate for solid dosage form
  • 7. ◦ Blood circulation to the site of application and the area of the absorbing surface in local applications. ◦ Physico-chemical parameters of the drug.  To reach he site of action the drug has to cross one or more membrane barriers .  The main process by which a drug molecule cross the neutral barrier is, ◦ Simple diffusion ◦ Facilitated diffusion ◦ Pore transport ◦ Diffusion of the ion across the membrane ◦ Active transport ◦ phagocytosis 7
  • 8. DISTRIBUTION:  Once the drug has been absorbed into the blood ,it distributed around the body. It get distributed throughout the blood supply , with in a minute. As the blood recirculates, the drug moves from the bloodstream into the body's tissues.  Drug is evenly distributed through out the blood supply, this does not mean the drug is evenly distributed around the body . Since he blood supply is rich in some areas of the body than the other. 8
  • 9.  Drugs penetrate different tissues at different speeds, depending on the drug's ability to cross membranes. For example, the anesthetic thiopental, a highly fat-soluble drug, rapidly enters the brain, but the antibiotic penicillin, a water- soluble drug, does not. In general, fat-soluble drugs can cross cell membranes more quickly than water-soluble drugs can.  Distribution of a given drug may also vary from person to person. For instance, obese people may store large amounts of fat-soluble drugs, whereas very thin people may store relatively little. Older people, even when thin, may store large amounts of fat-soluble drugs because the proportion of body fat increases with aging. 9
  • 10. METABOLISM:  Drug metabolism is the chemical alteration of a drug by the body.  metabolism is what the body does to the drug, Some drugs are chemically altered by the body (metabolized). The substances that result from metabolism (metabolites) may be inactive, or they may be similar to or different from the original drug in therapeutic activity or toxicity. Some drugs, called prodrugs, are administered in an inactive form, which is metabolized into an active form. 10
  • 11.  The resulting metabolites produce the desired therapeutic effects. Metabolites may be metabolized further instead of being excreted from the body. The subsequent metabolites are then excreted . The termination of the drug effect is caused by bio transformation and excretion .all the substance in the circulatory system , including drugs ,metabolites ,and nutrients will pass through the liver.  A significant portion of the drug metabolised by hepatic enzyme to inactive chemical. 11
  • 12. Storage sites  Plasma proteins, certain tissues, neutral fat, bone and transcelluar fluids(gastro intestinal tract)are found to act as a drug reservoirs or storage sites for drugs.  Plasma proteins: approximately 6.5% of the blood constitute the proteins, of which 50% I albumin.  The drug can also be stored in the tissue depots. Neutral fat constitutes some 20%o 50% of body weight and constitutes a depot of considerable importance. 12
  • 13.  The more lipophilic the drug, the more likely it will concentrate in these pharmacologically inert depots. The ultra short acting, lipophilic barbiturate thiopental’s concentration rapidly decreases below its effective concentration following administration. It disappears into tissue protein, redistributes into body fat, and then slowly diffuses back out of the tissue depots but in concentrations too low for a pharmacological response.  In general, structural changes in the barbiturate series that favours partitioning into the lipid tissue stores decrease duration of action but increase central nervous system depression. Conversely, the barbiturates with the slowest onset of action and longest duration of action contain the more polar side chains. 13
  • 14. PROTEIN BINDING:  The reversible binding of protein with non-specific and non- functional site on the body protein with out showing any biological effect is called as protein binding.  Protein + drug Protein-drug complex ⇌  Depending on the whether the drug is a weak or strong acid ,base or is neutral. It can bind to single blood proteins to multiple proteins. The most significant protein involved in the binding of drug is albumin, which comprises more than half of blood volume. 14
  • 15.  protein binding values are normally given as the percentage of total plasma concentration of drug that is bound to all plasma protein. 15 Free drug(Df) + Free protein(Pf) Drug /protein complex (Dp) Total plasma concentration (Dt) = (Df) (Dp +
  • 16.  NEUTRAL FAT:  Since fat constituents around 10%(starvation) to 50% of the total body weight.it serves as a main storage site for drugs having a high partition coefficient(lipid/water system) or a high lipid solubility(thiobarbiturates). 16
  • 17. Drug Receptor Interactions RECEPTOR  A macromolecular component of the organism that binds the drug and initiates its effect.  Traditional model was a rigid “Lock and Key” – Lock  Receptor surface – Key  Drug or Ligand
  • 18. TYPES OF RECEPTORS Four Primary Receptor Families (i)Ligand-gated ion channels (ii) G-protein (Guanine nucleotide-regulatory protein) coupled receptors. iii) Tyrosine Kinase-linked Receptors (iv) Intracellular receptors regulating gene transcription
  • 20. Covalent interactions Ionic interactions Drug Receptor Interactions Hydrogen bonding interactions Vander Waals interactions Hydrophobic interactions
  • 21. Solubility: • The solubility of a substance at a given temperature is defined as the concentration of the dissolved solute, which is in equillibrium with the solid solute. • Sufficient solubility and membrane permeability is an important factor for oral absorption. • The measurement of aqueous solubility depends upon the following facts., 1) Buffer & Ionic strength 2) Polymorphism & Purity of the sample 3) pH 4) Super saturation 5) Thermodynamic Vs Kinetic solubility
  • 22.  In ascending homologous series, the Physico chemical properties like boiling point, viscosity, surface activity and partition coefficient increases then the aqueous solubility decreases.  The solubility characteristics of a drug can be increased or decreased by derivatisation.  Eg: Methyl predinisolone acetate(water insoluble) is changed to Methyl predinisolone Sodium succinate(water soluble).  Eg: Convertion of chloramphenicol(slightly soluble) to chloramphenicol Palmitate (insoluble)
  • 23.  Methods to improve solubility of drugs 1) Structural modification 2) Use of co solvents 3) Employing surfactants 4) Complexation
  • 24. Partition Co-efficient  Partition co-efficient is one of the Physico chemical parameter which influencing the drug transport & drug distribution., the way in which the drug reaches the site of action from the site of application.  Partition co-efficient is defined as equilibrium constant of drug concentration for a molecule in two phases.  P[Unionized molecule] = [drug]lipid [drug]water P[Ionized molecule] = [drug]lipid [1-a ][drug]water a=degree of ionization in aqueous solution.
  • 25.  Factors affecting Partition Co-efficient  pH  Cosolvents  Surfactant  Complexation  Partition Co-efficient are difficult to measure in living system.  They are usually determined in vitro 1-octanol as a lipid phase and phosphate buffer of pH 7.4 as the aqueous phase.
  • 26. • The Partition co-efficient, P is dimensionless and its logarithm, log P is widely used as the measure of lipophilicity. • The log P is measured by the following methods. 1) Shake flask method 2) Chromatographic method 3) Spectroscopy method • Phenobarbitone has a high lipid/water partition coefficient of 5.9. Thiopentone sodium has a chloroform/water partition coefficient of about 100, so it is highly soluble in lipid.
  • 27. Surface Activity:  surfactant is defined as a material that can reduce the surface tention of water at low concentration.  Surface active agents affect the drug absorption which depends on: 1.The chemical nature of surfactant 2.Its concentration 3.Its affect on biological membrane and the miscelle formation.
  • 28.  At lower concentration the surfactant enhances the absorption rate, the same in higher concentration reduce the absorption rate. Applications: 1.The antihelmentic activity of hexylresorcinol 2.Bactericidal activity of cationic quaternary ammonium compounds. 3.Bactericidal activity of aliphatic alcohols. 4.Disinfectant action of phenol and cresol.
  • 29. Hydrogen Bond  The hydrogen bond is a special dipole-dipole interaction between non bonding electron pairs of hetero atoms like N, S, O and electron deficient hydrogen atom in polar bonds such as OH, NH, F etc. These are weak bonds and denoted as dotted lines. O-H…….O, HN-H…….O, • The compounds that are capable, of forming hydrogen bonding is only soluble in water.
  • 30.  Hydrogen bonding is classified in 2 types. 1) Intermolecular hydrogen bonding R-O-H H O R H-O-R H H O H H O H O H H
  • 31. 2) Intramolecular Hydrogen bonding salicylic acid o- nitrophenol O H C O OH O H N O O
  • 32. Hydrogen Bonding and biological action Eg. 1) Antipyrin i.e. 1- phenyl 2,3- dimethyl 5- pyrazolone has analgesic activity. N N CH3 H3C O C6H5 HN H3C O C6H5 HN H N H3C O 1-phenyl-3-methyl-5-pyrazolone is inactive. 1-phenyl-3-methyl-5-pyrazolone is inactive.
  • 33. C O H O OH Salicylic acid(O-Hydroxy Benzoic acid has antebacterial activity Salicylic acid(O-Hydroxy Benzoic acid has antebacterial activity OH C OH O HO C O OH para and meta Hydroxy Benzoic acids are inactive. para and meta Hydroxy Benzoic acids are inactive.
  • 34. CHELATION  DEFINITON: The compounds that are obtained by donating electrons to a metal Ion with the formation of a ring structure are called chelates.  LIGANDS: The compounds capable of forming a ring structure with a metal are termed as ligands.
  • 35. Importance of chelates in medicine: CH2SH CHSH CH2OH + As++ CH2S CHS CH2OH As a)Antidote for metal poisoning 1.Dimercaprol is a chelating agent. CH3 C CH3 SH H C NH2 COOH CU++ CH3 C CH3 S H C NH2 COOH CU CH3 C CH3 S H C NH2 COOH UC NH2 S HOOC CH3 CH3 2.Penicillamine 2.Penicillamine 1:1 chelate 1:2 chelate
  • 36.  b)8-Hydroxyquinoline and its analogs acts as antibacterial and anti fungal agent by complexing with iron or copper.  C) Undesirable side effects caused by drugs, which chelates with metals .  A side effect of Hydralazine a antihypertensive agent is formation of anemia and this is due to chelation of the drug with iron.
  • 37. Redox Potential:  The oxidation-reduction potential may be defined as a quantitative expression of the tendency that a compound has to give or receive electrons.  The redox potential of a system may be calculated from the following equation.  E=E0+0.0592/n log[conc. of reductant /conc.of oxidant]  Examples of interfering with natural redox system in biological conditions:  1) Riboflavin analogues  The biological activity of riboflavin is due to E =-0.185 volt.
  • 38. Examples, 1) Riboflavin analogues The biological activity of riboflavin is due to E =- 0.185 volt. N NH O N OH OH OH OH N O riboflavin Riboflavin E0 = -0.185 V Riboflavin analogue E0 = -0.095V N NH O N OH OH OH OH N O Dichloro riboflavin Cl Cl 2).The optimum bacteriostatic activity in quinones is associated with the redox potential at +0.03 volt, when tested against Staphylococcus aureus.
  • 39. Ionisation and Pka  Most of the drugs are either weak acids or base and can exist in either ionised or unionised state.  The ionisation of the drug depends on its pKa & pH.  The rate of drug absorption is directly proportional to the concentration of the drug at absorbable form but not the concentration of the drug at the absorption site.  Eg: Aspirin in stomach will get readily absorbed because it is in the un-ionosed form(99%).  Eg; Barbituric acid is inactive because it is strong acid. 5,5 disubstituted Barbituric acid has CNS depressant action because it is weak acid.
  • 40. Acids are two types-Unionized acid - HA Ionized acid - BH + According to Henderson-Hasselbalch equation PH = pka +log[Un ionised form][ionised form % ionisation = 100( 1+10 (pH-pka) ) HA H2O H3O+ A- BH+ H2O H3O+ B Unionized Acid Conjugate acid Conugate base ionised Conugate acid Conugate base
  • 41.  By using drug pKa, the formulation can be adusted to pH to ensure maximum solubility in water or maximum solubility in non-polar solvent.  The PH of a substance can be adjusted to maintain water solubility and complete ionisation.
  • 42.  Eg:Phenytoin injection must be adjusted to Ph 12 with Sodium Hydroxide to obtain 99.98% of the drug in ionised form.  Tropicamide eye drops,an anti cholinergic drug has a pka of 5.2 and the drug has to be buffered to Ph 4 to obtain more than 90% ionisation.
  • 43. OH O H OH O H trans-diethylstibesterol Estrogenic activity cis-diethylstibesterol Only 7% activity of the trans isomer The drug most possess a high degree of structural specificity or stereo selectivity. Many drugs show stereo selectivity because mostly reeptor binds are optically active biological macromolecules such as protein, polynuclootide or glycolipds. For e.g. Diethyl stilbosterol
  • 44. Conformational Isomers  Different arrangement of atoms that can be converted into one another by rotation about single bonds are called conformations.  Rotation about bonds allows inter conversion of conformers.
  • 45.  A classical example is of acetylcholine which can exist in different conformations. Staggered 2-Acetoxycyclo propyl trimethyl ammonium iodide H H N+ H H OCOCH3 H H N+ H H OCOCH3 Eclipsed H3COCO H N H H H GAUCHE H OCOCH3 N H H H Fully Eclipsed N+ O O I-
  • 46.  Optical Isomers  Stereochemistry, enantiomers, symmetry and chirality are impotant concept in therapeutic and toxic effect of drug.  A chiral compound containing one asymmetric centre has two enantiomers. Although each enantiomer has identical chemical & physical properties, they may have different physiological activity like interaction with receptor, metabolism & protein binding.  A optical isomers in biological action is due to one isomer being able to achieve a three point attachment with its receptor molecule while its enantiomer would only be able to achieve a two point attachment with the same molecule.
  • 48. E.g. Ephedrine & Psuedoephedrine MP = 37-39 1 gram/20 mL MP = 118-120 1 gram/200 mL Ephedrine (Erythro) CH3 OH H NHCH3 H Pseudoephedrine (Threo) CH3 H O H NHCH3 H
  • 49.  The category of drugs where the two isomers have qualitatively similar pharmacological activity but have different quantitative potencies. O O OH O (s)-(-)warfarin O O OH O (R)-(+)warfarin
  • 50. Geometric Isomerism Geometric isomerism is represented by cis/trans isomerism resulting from restricted rotation due to carbon carbon double bond or in rigid ring system. OH O H OH O H trans-diethylstibesterol Estrogenic activity cis-diethylstibesterol Only 7% activity of the trans isomer
  • 51.  Longmuir introduced the term isosterism in 1919, which postulated that two molecules or molecular fragments containing an identical number and arrangament of electron should have similar properties and termed as isosteres.  Isosteres should be isoelectric i.e. they should possess same total charge.
  • 52.  Bioisosterism is defined as compounds or groups that possess near or equal molecular shapes and volumes, approximately the same distribution of electron and which exhibit similar physical properties.  They are classified into two types., i)Classical biososteres ii)Non classical bioisosters.
  • 53.  Classical Bioisosteres  They have similarities of shape and electronic configuration of atoms, groups and molecules which they replace.  The classical bioisosteres may be, Univalent atoms and groups i)cl, Br, I ii) CH3NH2, -OH, -SH Bivalent atoms and groups i) R-OR,RNH-R, RSR,RSeR ii) –CONHR, -COOR, -COSR
  • 54.  Trivalent atoms and groups i)-CH=, -N= ii) –p=, -AS=  Tetravalent atoms and groups =c=, =N=, =P=
  • 55.  Application of Classical Bioisosteres in in drug design i) Replacement of –NH 2 group by –CH3 group. Carbutamide R= NH2 Tolbutamide R= CH3 ii)Replacement of –OH & -SH Guanine= -OH 6-Thioguanine = -SH R SO2 NH CONH(CH2)3CH3 NH N N H2N HN X
  • 56.  Non classical Bioisosteres  They do not obey the stearic and electronic definition of classical isosteres.  These isosteres retain activity by the retention of their properties such as pKa, electrostatic potentials, which can alter selective enzyme processes.
  • 57.  Examples  Halogens cl, F, Br,CN  Ether -S-, -O-  Carbonyl group  Hydroxyl group –OH, -NHSO2R, CH2OH  Catechol HO HO Catechol O S O O N H N
  • 58.  A classical e.g. of ring Vs. noncycclic structure is Diethylstilbosterol & 17-ß oestradiol. 17-ß oestradiol. HO OH H H H OH HO trans-diethylstibesterol
  • 59. REFERENCES: 1.Thomas L . LEMKE , David A . WILLIAMS , Victoria F.ROCHE,S . William ZITO, Foye’s Principles of Medicinal Chemistry ,Wolters kluwer Pvt .Ltd, New Delhi , 6th Edition ,Pg . no. 210 – 298. 2.William A.Remers,Jaimes N .Delgado, Wilson& Grissvold’s Text book of organic, Medicinal and pharmaceutical Chemistry ,10th Edition ,Pg .no.3-10 59
  • 60. 3. DonaldJ. Abraham ,BURGER’S Medicinal chemistry Drug Discovery , Wiley inter science publication , 6th Edition ,Volume -2, Pg. no. 649 – 653. 4. Rama rao Nadendla ,Principles of organic Medicinal Chemistry , New age International Pvt . Limited Publishers , Pg . no. 14 - 28. 5. www.wikipedia.com 60